Core Insights - The medical ETF (159828) has seen an inflow of 10 million shares today, with a net inflow of 2 million shares, indicating strong demand for medical assets [1] - AI healthcare is characterized by advanced technologies such as machine learning, natural language processing, and computer vision, which analyze complex medical data to assist clinical decision-making and optimize treatment processes [1] - The AI healthcare industry in China was valued at 97.3 billion yuan in 2023 and is projected to reach 159.8 billion yuan by 2028, with a compound annual growth rate (CAGR) of 10.5% from 2022 to 2028 [1] - The AI medical imaging and AI pharmaceuticals segments are experiencing rapid growth, supported by favorable policies that accelerate the implementation of AI healthcare technologies [1] - The medical ETF (159828) tracks the CSI Medical Index (399989), which selects listed companies in the pharmaceutical and healthcare sectors, primarily covering medical devices, medical services, and medical research outsourcing [1] - The index components are skewed towards small and mid-cap stocks, which exhibit higher growth potential and volatility [1]
AI医疗前景广阔，医疗ETF（159828）今日流入1000万份，连续5日迎资金净流入
Sou Hu Cai Jing·2025-11-06 09:00